Tourette Association of America
12
1
1
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
8.3%
1 terminated/withdrawn out of 12 trials
90.9%
+4.4% vs industry average
0%
0 trials in Phase 3/4
10%
1 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Theta Burst Stimulation to Improve Inhibitory Motor Physiology in Tourette Syndrome
Role: collaborator
Tourette Discrimination (TD) Stigma Scale
Role: collaborator
Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study
Role: collaborator
Investigating Distress Tolerance in Adults With Tourette Syndrome
Role: collaborator
Anger Control Training for Youth With Tourette Syndrome
Role: collaborator
Behavioral Therapy for Tourette Syndrome
Role: collaborator
Incorporating teleCBIT Into a Hospital-Based Tic Program
Role: collaborator
Transcranial Magnetic Stimulation (TMS) for Individuals With Tourette's Syndrome
Role: collaborator
FAAH Inhibitor Trial for Adults With Tourette Syndrome
Role: collaborator
Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
Role: lead
Developing Cognitive Training for Tourette Syndrome
Role: collaborator
Omega-3 Fatty Acids in Tourette's Disorder
Role: collaborator
All 12 trials loaded